Healthcare Financing

Bristol Myers Squibb (BMS) has reinforced its collaboration with Cellares by signing a $380 million agreement, [...]

Regeneron Pharmaceuticals is venturing into the investment domain, allocating up to $500 million for its new [...]

The economy defies expectations with its sustained growth despite high-interest rates that traditionally dampen economic activity. [...]

Addex Therapeutics, a Swiss biotech firm, has spun off its neuroscience research and allosteric modulator platform [...]

In the wake of GSK's $2 billion acquisition of Bellus Health, an undisclosed number of Bellus [...]

UnitedHealth Group has distributed over $2 billion in advance payments to healthcare providers impacted by a [...]

Just days after the FDA’s fiscal year 2024 appropriations package was passed, the Biden administration is [...]

Chris Viehbacher, Biogen’s CEO, remains optimistic about the company’s future despite current financial difficulties. Biogen has [...]

Kyverna Therapeutics, under CEO Peter Maag, Ph., has recently completed a $319 million Initial Public Offering [...]

AstraZeneca announced a $300 million investment in a new facility in Rockville, Maryland, dedicated to discovering [...]

Merck’s Keytruda has emerged as the world’s top-selling drug in 2023, with sales reaching $25 billion, [...]

The Centers for Medicare & Medicaid Services (CMS) has initiated Medicare price negotiations for the first [...]

Year-end earnings for 2023 have been reported by major pharma companies Novo Nordisk, GSK, and Novartis, [...]

Abbott's latest earnings report revealed mixed results. In Q4 2023, the company's net sales rose 1.5% [...]

In 2020, AARP identified the top 10 drugs with price increases exceeding the 1.3% inflation rate. [...]

The biotech industry is grappling with a bear market, leading investors to adopt more cautious strategies. [...]

In 2023, a continuous glucose monitor manufacturer, Dexcom, reported a significant year marked by a major [...]

Boston Scientific has announced a $3.7 billion acquisition of Axonics, a key player in neurostimulation therapies [...]

Merck has agreed to acquire Harpoon Therapeutics for $680 million, significantly enhancing its cancer treatment portfolio [...]

Walgreens Boots Alliance, under the new leadership of CEO Tim Wentworth, is preparing to adopt new [...]

Boehringer Ingelheim is partnering with Chinese biotech Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals [...]

Key challenges identified by a GlobalData survey include inflation, geopolitical conflict, and drug pricing pressures. Inflation [...]